Worth $44m
The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical, its women’s healthcare unit, has acquired EndoSee Corporation, a developer of an office-based disposable hysteroscopy system.
The transaction is valued at approximately $44 million and is expected to be neutral to fiscal 2015 earnings per share excluding one-time charges and deal-related amortization.
Commenting on the transaction, Robert S. Weiss, Cooper’s president and chief executive officer, said, “The acquisition of EndoSee fits perfectly with CooperSurgical’s office/surgical strategy of bringing high quality products to the OB/GYN while leveraging our infrastructure. This product has been cleared by the FDA and we plan to launch the product in the U.S. in the middle of fiscal 2015.”
The Cooper Companies is a global medical device company that operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women’s health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has approximately 9,000 employees with products sold in over 100 countries.
EndoSee Corporation, headquartered in Los Altos, California, is a privately held company that specializes in the development of a disposable office-based hysteroscopy system. The EndoSee Office Hysteroscope is a handheld, battery-operated, readily portable system that requires minimal setup and is easy to use. The system consists of a HandTower – incorporating a rechargeable battery, video and control electronics, and touch screen LCD display – and a sterile, disposable hysteroscopic cannula with a camera and light source at the tip and which enables distention of the uterine cavity for optimal visualization.